A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.
A phase 1/2 trial of ONO-4538HSC in epithelioid sarcoma, run by Ono Pharmaceutical Co., Ltd., now recruiting.
Overview
A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma. is a phase 1/2 interventional study registered as NCT07734116 by Ono Pharmaceutical Co., Ltd., with 50 participants planned, started 2026-08-18 and due to reach its primary completion in 2029-11-30. Interventions recorded: ONO-4538HSC.
Similar pages
not linked directly; found by shared links- TrialINTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.
- TrialA Master Protocol to Evaluate DCC-3009 in Gastrointestinal Stromal Tumor (GIST)
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.
- TrialA Study of E7389 Liposomal Formulation (E7389-LF) Plus Nivolumab in Participants With Solid Tumor
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.
- TrialA Study to Investigate the Efficacy and Safety of ONO-4578 in Combination With Nivolumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.
- TrialA Study to Evaluate the Efficacy and Safety of ONO-4538 in Combination With Ipilimumab and Chemotherapy in Chemotherapy-naïve Participants With HER2-negative Unresectable Advanced or Recurrent Gastric Cancer (Including Esophagogastric Junction Cancer)
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.
- TrialEvaluate the Safety and Clinical Activity of HH2853
Shares Epithelioid sarcoma and the tag pipeline.
- TrialA Study of Ripretinib vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.
- TrialA Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies
Shares Deciphera Pharmaceuticals (Ono) and the tag pipeline.